English中文

Offstream
news



Changes

  1. Hungary grants the approval of the CanSino Biologics' Convidecia vaccine based on the interim results of its phase III trial.
  2. Hungary grants the emergency use approval of the CanSino Biologics' Convidecia and Indian Covishield vaccines.
  3. Hungary grants emergency use approval for the CanSino Biologics Convidecia and Indian Covishield vaccines.
  4. Hungary grants emergency use approval for the CanSino Biologics Convidecia and Indian Covishield COVID-19 vaccines.

Related